Breaking News Instant updates and real-time market news.

JKS

JinkoSolar

$27.78

0.14 (0.51%)

, JASO

JA Solar

$8.14

0.25 (3.17%)

11:21
09/19/17
09/19
11:21
09/19/17
11:21

EU eases trade restrictions on Chinese solar panels, People's Daily reports

China has welcomed the European Union's decision to ease trade restrictions on Chinese solar panels after the EU approved plans to no longer cap import volume and to gradually lower the minimum price at which imported products must be sold, the People's Daily reports, citing Wang Hejun, head of the Ministry of Commerce's trade remedy and investigation bureau. "China hopes the EU could completely terminate its trade restrictions on Chinese PV products to provide a more stable and predictable business environment and achieve mutual benefits in the sector," Wang said. Chinese solar energy companies include JinkoSolar (JKS) and JA Solar (JASO). Canadian Solar (CSIQ) also has a large China business. Reference Link

JKS

JinkoSolar

$27.78

0.14 (0.51%)

JASO

JA Solar

$8.14

0.25 (3.17%)

CSIQ

Canadian Solar

$16.80

-0.47 (-2.72%)

JKS JinkoSolar
$27.78

0.14 (0.51%)

05/26/17
05/26/17
DOWNGRADE
Target $16.4

Underweight
JinkoSolar downgraded two notches to Underweight at Morgan Stanley
As previously reported, Morgan Stanley downgraded JinkoSolar two notches to Underweight from Overweight and lowered its price target to $16.40 from $19.40. Analyst Sheng Zhong expects Q1 earnings to decline over 50% below Street estimates mainly due to lower margins and ASPs, and slow cost reductions given high polysilicon prices and OEM fees. The analyst also notes increased new capacity coming online and believes a majority of manufacturers will have difficulty reaching breakeven in 2H 2017 and 2018.
05/26/17
05/26/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral on balanced risk/reward at Buckingham with the firm citing more balanced risk/reward at current levels and raised its price target to $330 from $325. 2. JinkoSolar (JKS) was downgraded to Sell from Neutral at Citi and to Underweight from Overweight at Morgan Stanley. 3. Signet Jewelers (SIG) downgraded to Neutral from Buy at CL King with the firm citing lack of catalysts. 4. TripAdvisor (TRIP) downgraded to Underperform from Neutral at Macquarie with analyst Matthew Brooks saying the "best days" may be over for TripAdvisor and believes Google (GOOGL) is at the "top of the travel funnel." 5. Shire (SHPG) downgraded to Market Perform from Outperform at Bernstein with analyst Aaron Gal saying he believes risks to longer term earnings from competition and slowing Vyvanse sales are not being factored into consensus estimates. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/15/17
COKE
08/15/17
NO CHANGE
COKE
Sell
Coker Palmer calls JinkoSolar's capital market activity 'egregious'
JinkoSolar's (JKS) $200M mixed securities shelf filing this morning it its third secondary since the initial public offering, Coker Palmer writes in a research note. The company's capital market activity and spending are "egregious" and not helping the industry return to a more rationale pricing environment, the firm contends. Coker believes JinkoSolar is unlikely to generate any free cash flow in 2017/2018. It continues to recommend being long Canadian Solar (CSIQ) and short Jinko.
08/22/17
FBCO
08/22/17
DOWNGRADE
Target $25
FBCO
Neutral
JinkoSolar downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Maheep Mandloi downgraded JinkoSolar to Neutral and raised his price target to $25 from $20 saying current valuation does not reflect oversupply in 2018+. The analyst raised Jinko estimates well above consensus as demand improves and higher efficiency products but said investors are too "exuberant" on demand growth.
JASO JA Solar
$8.14

0.25 (3.17%)

08/29/17
AXIO
08/29/17
DOWNGRADE
Target $5
AXIO
Sell
JA Solar downgraded to Sell from Hold at Axiom
Axiom analyst Gordon Johnson downgraded JA Solar to Sell saying recent results suggest that Chinese module vendors are not benefiting significantly from any U.S. demand pull-in. Further, the analyst notes that module prices are down 1.8% over the past two weeks. Johnson sees risk to consensus estimates and cut his price target for JA Solar shares to $5 from $7.
08/24/17
AXIO
08/24/17
NO CHANGE
AXIO
JA Solar likely to report Q3 loss, says Axiom
Axiom analyst Gordon L Johnson III says his recent checks indicate that China and global prices for modules and cell dropped slightly last week, while spot prices for polysilicon and multi wafers used to make solar modules and cells rose sharply from July 12 to August 9 and have since been stable. As a result, the analyst calculates that companies which bought the raw materials at spot prices have seen their margins on solar cells fall to a record low -12.9%, while module makers who bought the raw materials at spot prices have margins of -3.7%, the lowest level since Axiom began tracking them. Given these trends, Johnson predicts that JA Solar will report a Q3 pretax loss of $10M and warns that the company's results could deteriorate further in Q4. Other publicly traded companies in the space include Canadian Solar (CSIQ), First Solar (FSLR), SunEdison (SUNEQ), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).
08/29/17
08/29/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. JA Solar (JASO) downgraded to Sell from Hold at Axiom with analyst Gordon Johnson saying recent results suggest that Chinese module vendors are not benefiting significantly from any U.S. demand pull-in. 2. Finish Line (FINL) was downgraded to Sell from Neutral at Citi and Deutsche Bank, while being downgraded to Underperform from Neutral at Buckingham, and to Neutral from Buy at FBR Capital. 3. Intellia Therapeutics (NTLA) downgraded to Neutral from Buy at Chardan with analyst Madhu Kumar citing relative valuation. 4. Loxo Oncology (LOXO) downgraded to Market Perform from Outperform at JMP Securities with analyst Michael King saying he believes the company's platform and assets under development are now being fairly valued with the stock having risen above his $71 price target. 5. Cemex (CX) downgraded to Neutral from Buy at BofA/Merrill with analyst Carlos Peyrelongue citing lack of positive catalysts and risk of disappointment in Mexico and the U.S. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/17
AXIO
07/19/17
UPGRADE
Target $7
AXIO
Hold
JA Solar upgraded to Hold from Sell at Axiom
Axiom analyst Gordon L. Johnson II upgraded JA Solar to Hold from Sell stating that he believes the company will "opportunistically attack" the U.S. market as long as the bull market for solar panels is "in play". The company's standing $9.69 per share take private offer from its CEO caps the stock's upside, however, added Johnson, who raised his price target on JA Solar to $7 from $3.
CSIQ Canadian Solar
$16.80

-0.47 (-2.72%)

08/21/17
LEHM
08/21/17
DOWNGRADE
Target $14
LEHM
Underweight
Canadian Solar downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Jon Windham downgraded Canadian Solar to Underweight following Q2 results saying it faces risks from the possible delay of project sales and pricing, soft investor demand for a J-REIT listing in the second half, and risks from the September 22 injury vote in the US ITC 201 trade case. Windham raised Canadian Solar's price target to $14 from $12.
08/21/17
08/21/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Hold from Buy at Jefferies, with analyst Randal Konik saying valuation is expensive and the competitive landscape could make share gains and margin expansion difficult. Konik added Adidas' (ADDYY) success in reviving its brand appeal in North America has had a clear impact on Nike shares. 2. Foot Locker (FL) downgraded to Neutral from Buy at UBS and Finish Line (FINL) cut to Sell from Neutral by analyst Michael Binetti, who said Foot Locker's results were worse than the analyst expected and make it tougher to support a thesis that athletic retail will be able to sidestep the structural challenges of the broader sector. Binetti downgraded Finish Line based on the structural risks exposed by Foot Locker exposed in its Q2 report. 3. Barclays analyst Lydia Rainforth downgraded Total (TOT) and Repsol (REPYY) to Equal Weight from Overweight and Statoil (STO) and Eni SpA (E) to Underweight from Equal Weight citing relative valuation. 4. Canadian Solar (CSIQ) downgraded to Underweight from Equal Weight at Barclays, with analyst Jon Windham saying it faces risks from the possible delay of project sales and pricing, soft investor demand for a J-REIT listing in the second half, and risks from the September 22 injury vote in the US ITC 201 trade case. 5. Infosys (INFY) downgraded to Neutral from Overweight at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

AYI

Acuity Brands

$161.46

3.9 (2.48%)

21:35
09/20/18
09/20
21:35
09/20/18
21:35
Upgrade
Acuity Brands rating change  »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

TTNP

Titan Pharmaceuticals

$0.50

-0.08 (-13.79%)

21:34
09/20/18
09/20
21:34
09/20/18
21:34
Syndicate
Titan Pharmaceuticals raises $9.5M in a public offering »

The securities offered by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MTEM

Molecular Templates

$5.81

-0.44 (-7.04%)

21:31
09/20/18
09/20
21:31
09/20/18
21:31
Syndicate
Molecular Templates 8.2M share Secondary priced at $5.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

YMAB

Y-mAbs Therapeutics

$0.00

(0.00%)

21:30
09/20/18
09/20
21:30
09/20/18
21:30
Syndicate
Y-mAbs Therapeutics 6M share IPO priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

VKTX

Viking Therapeutics

$18.92

-0.72 (-3.67%)

21:28
09/20/18
09/20
21:28
09/20/18
21:28
Syndicate
Viking Therapeutics 9.5M share Secondary priced at $18.50 »

William Blair, SunTrust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

TWIN

Twin Disc

$23.33

0.34 (1.48%)

21:28
09/20/18
09/20
21:28
09/20/18
21:28
Syndicate
Twin Disc 1.333M share Secondary priced at $22.50 »

Baird and Oppenheimer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FTCH

Farfetch

$0.00

(0.00%)

21:26
09/20/18
09/20
21:26
09/20/18
21:26
Syndicate
Farfetch 44.244M share IPO priced at $20.00, above the range »

Goldman Sachs, JPMorgan,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

21:25
09/20/18
09/20
21:25
09/20/18
21:25
Syndicate
Crispr Therapeutics 4.211M share Secondary priced at $47.50 »

Goldman Sachs, Piper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

MDCA

MDC Partners

$4.55

0.25 (5.81%)

21:08
09/20/18
09/20
21:08
09/20/18
21:08
Hot Stocks
MDC Partners to evaluate strategic alternatives »

MDC Partners announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRE

Guidewire

$101.71

0.16 (0.16%)

20:27
09/20/18
09/20
20:27
09/20/18
20:27
Hot Stocks
Guidewire sees 5-year target revenue of about $1.3B »

Sees % subscription of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

AVMXY

Avita Medical

$0.00

(0.00%)

20:13
09/20/18
09/20
20:13
09/20/18
20:13
Hot Stocks
Avita Medical announces FDA approval of RECELL in burn treatment »

AVITA Medica announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTS

Ladenburg Thalmann

$2.36

-0.03 (-1.26%)

20:05
09/20/18
09/20
20:05
09/20/18
20:05
Hot Stocks
Ladenburg Thalmann CEO to serve as chairman »

Ladenburg Thalmann…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

19:25
09/20/18
09/20
19:25
09/20/18
19:25
Conference/Events
Morgan Stanley multi-industrial analysts hold analyst/industry conference call »

U.S. Electrical Equipment…

SPY

SPDR S&P 500 ETF Trust

$293.53

2.31 (0.79%)

, SPX

S&P 500

$0.00

(0.00%)

19:15
09/20/18
09/20
19:15
09/20/18
19:15
General news
Trump's former lawyer Cohen met with Mueller multiple times, ABC says »

President Donald…

SPY

SPDR S&P 500 ETF Trust

$293.53

2.31 (0.79%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$16.10

0.8 (5.23%)

, ACAD

Acadia

$19.08

3.97 (26.27%)

19:09
09/20/18
09/20
19:09
09/20/18
19:09
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

SCS

Steelcase

$16.10

0.8 (5.23%)

ACAD

Acadia

$19.08

3.97 (26.27%)

TXN

Texas Instruments

$108.50

1.14 (1.06%)

MCD

McDonald's

$160.84

1.65 (1.04%)

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

MU

Micron

$46.06

1.01 (2.24%)

SGH

Smart Global

$30.44

0.7 (2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 01

    Oct

  • 04

    Oct

  • 10

    Oct

  • 28

    Oct

KORS

Michael Kors

$72.72

-0.33 (-0.45%)

19:01
09/20/18
09/20
19:01
09/20/18
19:01
Hot Stocks
Michael Kors names Andrea Pesaresi head of Men's business »

Michael Kors Holdings is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MDT

Medtronic

$97.47

1.01 (1.05%)

, MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

19:00
09/20/18
09/20
19:00
09/20/18
19:00
Hot Stocks
Medtronic to acquire Mazor Robotics for $58.50 per ADS, or about $1.64B »

Medtronic (MDT) and Mazor…

MDT

Medtronic

$97.47

1.01 (1.05%)

MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

MDT

Medtronic

$97.47

1.01 (1.05%)

, MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

18:59
09/20/18
09/20
18:59
09/20/18
18:59
Hot Stocks
Breaking Hot Stocks news story on Medtronic, Mazor Robotics »

Medtronic to acquire…

MDT

Medtronic

$97.47

1.01 (1.05%)

MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

ACAD

Acadia

$19.08

3.97 (26.27%)

18:54
09/20/18
09/20
18:54
09/20/18
18:54
Upgrade
Acadia rating change at Piper Jaffray »

Acadia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ACAD

Acadia

$19.08

3.97 (26.27%)

18:48
09/20/18
09/20
18:48
09/20/18
18:48
Upgrade
Acadia rating change at Piper Jaffray »

Acadia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SONA

Southern National Bancorp

$16.89

0.13 (0.78%)

18:45
09/20/18
09/20
18:45
09/20/18
18:45
Hot Stocks
Southern National Bancorp names Jeffrey Karafa CFO »

Southern National Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$298.32

-0.63 (-0.21%)

18:44
09/20/18
09/20
18:44
09/20/18
18:44
Periodicals
Tesla VP of global supply management O'Connor to leave company, Bloomberg says »

Liam O'Connor,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 29

    Oct

CRBP

Corbus Pharmaceuticals

$7.90

2.75 (53.40%)

18:34
09/20/18
09/20
18:34
09/20/18
18:34
Hot Stocks
Corbus CEO says wants to be leading pipeline for synthetic endocannabinoids »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

MCD

McDonald's

$160.84

1.65 (1.04%)

18:32
09/20/18
09/20
18:32
09/20/18
18:32
Hot Stocks
McDonald's says dividend hike reinforces confidence in long-term targets »

McDonald's says the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MCD

McDonald's

$160.84

1.65 (1.04%)

18:31
09/20/18
09/20
18:31
09/20/18
18:31
Hot Stocks
McDonald's raises quarterly dividendy by 15% to $1.16 per share »

McDonald's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.